Unknown

Dataset Information

0

PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer.


ABSTRACT:

SUBMITTER: Roncolato F 

PROVIDER: S-EPMC6953296 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer.

Roncolato Felicia F   Lindemann Kristina K   Willson Melina L ML   Martyn Julie J   Mileshkin Linda L  

The Cochrane database of systematic reviews 20191007


<h4>Background</h4>Endometrial cancer is one of the most common gynaecological cancers in developed countries. Treatment of advanced endometrial cancer usually involves radiotherapy, chemotherapy, endocrine therapy or a combination of these. However, survival outcomes are poor in advanced or metastatic disease. Better systemic treatment options are needed to improve survival and safety outcomes for these women. The PI3K/AKT/mTOR pathway is a frequently altered signalling pathway in endometrial c  ...[more]

Similar Datasets

| S-EPMC4706528 | biostudies-literature
| S-EPMC3913524 | biostudies-literature
| S-EPMC3072168 | biostudies-literature
| S-EPMC8903758 | biostudies-literature
| S-EPMC3413814 | biostudies-literature
| S-EPMC3604032 | biostudies-literature
| S-EPMC7388095 | biostudies-literature
| S-EPMC8616154 | biostudies-literature
| S-EPMC9406657 | biostudies-literature